Infectious Disease Diagnostics Market to Witness Unprecedented Growth By 2026

Infectious Disease Diagnostics Market Size,
Share, Trend, Outlook, Future Growth
Analysis And Synthesis 2018 - 2026
Infectious diseases are caused by organisms such as bacteria, viruses, fungi, and
capable of transmission from one species to another species. Diagnosis of these
identifying the pathogen and its type and the degree up to which the infection has
diseases such as HIV, tuberculosis, malaria, and Influenza are highly prevalent and
diagnosed with the help of diagnostic tests available for the respective diseases.
parasites and are
diseases involves
spread. Infectious
can be efficiently
Technologies utilized by these diagnostic tests are classified into biochemical techniques, molecular
techniques, immunodiagnostics, and conventional culturing, and staining techniques. Biochemical
techniques include ELISA, agglutination, and others, while molecular techniques include Polymerase
Chain Reaction (PCR) and Next-Generation Sequencing techniques. These tests are capable of diagnosing
the infectious diseases accurately with high throughput capacity.
Request Sample of Report:
Increasing prevalence of various infectious diseases is expected to boost the infectious disease diagnostics
market growth over the forecast period
Infectious diseases such as HIV, tuberculosis, and malaria are prevalent in emerging economies such as
Africa and Asia Pacific. For instance, according to the World Health Organization (WHO), an estimated
36.7 million people were suffering from HIV in 2016.
According to the World Health Organization (WHO), in 2015, an estimated 32,000 deaths from
tuberculosis and around 323,000 new cases of TB cases were registered in the Europe. Moreover, around
323,000 incident of TB cases in this region includes 27,000 cases with HIV co-infection.
The global infectious disease diagnostics market size was valued at US$ 15,112.2 million in 2017, and is
expected to witness a robust CAGR of 6.1% over the forecast period (2018 – 2026).
Partnerships and collaborations by market players to develop novel diagnostic techniques is expected to
boost growth of the infectious disease diagnostics market
Individual organizations, manufacturers, and research institutes are forming partnerships, and
collaborations to advance research and development of diagnostic tests for infectious diseases. Moreover,
funding by individual organizations to advance research is expected to boost the growth of the market
over the forecast period. For instance, the University of Virginia’s Global Infectious Diseases Institute
funded seven projects designed to tackle challenging problems in infectious diseases worldwide in July
2018. They have formed collaborative teams across diverse academic disciplines to control and treat Zika
virus infections and to reduce tuberculosis rates among HIV-infected patients in Africa.
Report includes chapters which deeply display the following deliverable about industry :
• Infectious Disease Diagnostics Market Research Objective and Assumption
• Infectious Disease Diagnostics Market Purview - Report Description, Executive Summary, and
Coherent Opportunity Map (COM)
• Infectious Disease Diagnostics Market Dynamics, Regulations, and Trends Analysis - Market
Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system
Launch/Approvals, Value Chain Analysis, Porter’s Analysis, and PEST Analysis
• Global Infectious Disease Diagnostics Market, By Regions
• Infectious Disease Diagnostics Market Competition by Manufacturers including Production,
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.
• Infectious Disease Diagnostics Market Manufacturers Profiles/Analysis including Company Basic
Information, Manufacturing Base and Its Competitors.
• Infectious Disease Diagnostics Market Manufacturing Cost Analysis including Key Raw
Materials and Key Suppliers of Raw Materials.
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials
Sourcing and Downstream Buyers
• Marketing Strategy Analysis, Distributors/Traders including Marketing Channel, Market
Positioning and Distributors/Traders List.
• Market Effect Factors Analysis including Technology Progress/Risk, Consumer Needs/Customer
Preference Change and Economic/Political Environmental Change.
• Infectious Disease Diagnostics Market Forecast including Production, Consumption, Import and
Export Forecast by Type, Applications and Region.
• Research Findings and Conclusion
Key Players
Some of the major players operating in the global infectious disease diagnostics market include Danaher
Corporation, Abbott Laboratories, Becton, Dickinson, and Company, F.Hoffmann La-Roche Ltd., Trinity
Biotech Plc., Cardinal Health, Inc., BioMérieux, Bio-Rad Laboratories, Inc., AccuBioTech, Co. Ltd., and
Acon Laboratories, Inc.
Detailed Segmentation:
Global Infectious Disease Diagnostics Market, By Disease Type:
Healthcare Associated Infections (HAIs)
Human Papillomavirus (HPV)
Tuberculosis (TB)
Global Infectious Disease Diagnostics Market, By Technology:
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Browse Full Report:
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering actionready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]

The global infectious disease diagnostics market size was valued at US$ 15,112.2 million in 2017, and is expected to witness a robust CAGR of 6.1% By 2026.